(BUSINESS WIRE)--August 18, 2006--OMRIX Biopharmaceuticals, Inc. discovers, develops and manufactures innovative, novel technologies to provide safer and more effective options to patients with unmet medical needs, particularly in the areas of biosurgical and passive immunotherapy products. We are utilizing our proprietary protein purification technology, innovative development capabilities, and manufacturing know-how to develop these product lines, often through collaborations with companies whose marketing and sales expertise are a complement to our own areas of specialty.
